Gov't Approves First-Ever Med with Digital Tracking System

Gov't Approves First-Ever Med with Digital Tracking System

November 14, 2017 04:42 PM

WASHINGTON (AP) - The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system in an unprecedented step to ensure that patients with mental disorders take the medicine prescribed for them.

Advertisement – Content Continues Below

The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was initially approved for marketing in 2012. The agency says the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch."

Dr. Mitchell Mathis of the FDA says officials support "use of new technology in prescription drugs and is committed to working with companies to understand how the new technology might benefit patients and prescribers."


Copyright 2017 The Associated Press. All rights reserved.

Relay Media Amp

Police ID Rochester Stabbing Victims and Suspect

Bulldogs to Face MSU-Mankato in NCAA West Regional in Sioux Falls

Man Dies In NE Minneapolis House Fire

2 Men Fatally Stabbed In Salvation Army Apartment

UMD Hosts STEM Event For Local Youth

Duluth Waterfront Getting Close to New Rowing Center